{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,12]],"date-time":"2024-05-12T21:54:20Z","timestamp":1715550860937},"reference-count":78,"publisher":"Informa Healthcare","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2001,11]]},"DOI":"10.1517\/13543784.10.11.2013","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T19:21:13Z","timestamp":1115234473000},"page":"2013-2029","source":"Crossref","is-referenced-by-count":1,"title":["Alteplase: descendancy in myocardial infarction, ascendancy in stroke"],"prefix":"10.1517","volume":"10","author":[{"given":"Sheila A","family":"Doggrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CIT0001","first-page":"397","volume":"1","author":"THE GISSI INVESTIGATORS","year":"1986","journal-title":"Gruppo Italian\u00b0 per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.98.24.2659"},{"key":"CIT0003","first-page":"142","volume":"76","author":"CHESBRO JH","year":"1987","journal-title":"Clinical findings through hospital discharge. Circulation"},{"key":"CIT0004","first-page":"525","volume":"2","author":"WILCOX RG","year":"1988","journal-title":"CG etal.: Trial of tissue plasminogen activator of mortality reduction in acute MI. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet"},{"key":"CIT0006","first-page":"65","volume":"336","author":"THE GISSI-","year":"1990","journal-title":"Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. Lancet"},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)91590-7"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)91538-W"},{"key":"CIT0009","first-page":"746","volume":"90","author":"STEINBERG JS","year":"1994","journal-title":"Results of a multicenter randomised trial. LATE Ancillary Study Investigators. Late Assessment of Thrombolytic Efficacy. Circulation"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(94)00524-T"},{"key":"CIT0013","first-page":"1515","volume":"329","author":"THE GUSTO ANGIOGRAPHIC INVESTIGATORS","year":"1993","journal-title":"N Engl. J. Med."},{"key":"CIT0014","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.90.6.2658"},{"key":"CIT0015","first-page":"1233","volume":"94","author":"CALIFF RM","year":"1996","journal-title":"GUSTO-I Investigators. Circulation"},{"key":"CIT0017","first-page":"1923","volume":"91","author":"SIMES RJ","year":"1995","journal-title":"HOLMES DR JR etal.: Link between the angiographic substudy and mortality outcomes in a large randomised trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators. Circulation"},{"key":"CIT0018","first-page":"237","volume":"17","author":"BAARDMAN T","year":"1996","journal-title":"LENDERINK T etal.: Differential effects of tissue plasminogen activator and streptokinase on infarct size and on rate of enzyme release: influence of early infarct related artery patency. The GUSTO Enzyme Substudy. Eur. Heart J."},{"key":"CIT0019","first-page":"259","volume":"82","author":"GOLDBERG RJ","year":"1998","journal-title":"GURWITZ JH etal.: Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute MI (The second National Registry of Myocardial Infarction). Am. I Cordial."},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(88)80040-8"},{"key":"CIT0021","first-page":"885","volume":"19","author":"NEUHAUS KL","year":"1992","journal-title":"U etal.: Improved thrombolysis in acute MI with front-loaded administration of alteplase: results of the rt-PA-APSAC patency study (TAPS). J. Am. Coll. Cordial."},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(97)00370-7"},{"key":"CIT0025","first-page":"1124","volume":"336","author":"THE COBALT INVESTIGATORS","year":"1997","journal-title":"The Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators. N Engl. J. Med."},{"key":"CIT0026","first-page":"741","volume":"136","author":"BLEICH SD","year":"1998","journal-title":"DouBLE Study Investigators. Double Bolus Lysis Efficacy. Am. Heart J."},{"key":"CIT0027","first-page":"673","volume":"328","author":"GRINES CL","year":"1993","journal-title":"The Primary Angioplasty in Myocardial Infarction Study Group. N Engl. j Med."},{"key":"CIT0028","first-page":"66","volume":"26","author":"STONE GW","year":"1995","journal-title":"BROWNE KF etal.: Implications of recurrent ischaemia after reperfusion therapy in acute MI: a comparison of thrombolytic therapy and primary angioplasty. j Am. Coll. Cordial."},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(96)00220-2"},{"key":"CIT0030","first-page":"333","volume":"39","author":"STONE GW","year":"1996","journal-title":"BROWNE KF etal.: Outcome of different reperfusion strategies in patients with former contraindications to thrombolytic therapy: a comparison of primary angioplasty and tissue plasminogen activator. Primary Angioplasty in Myocardial Infarction (PAMI) Investigators. Gotha. Cardiovasc. Diagn."},{"key":"CIT0031","first-page":"640","volume":"33","author":"NUNN CM O&apos","year":"1999","journal-title":"Long-term outcome after primary angioplasty: report from the primary angioplasty in MI (PAMI-I) trial. j Am. Coll. Cordial."},{"key":"CIT0032","first-page":"1621","volume":"335","author":"THE GLOBAL USE OF STRATEGIES TO OPEN OCCLUDED CORONARY ARTERIES IN ACUTE CORONARY SYNDROMES","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00579-8"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00446-X"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00644-5"},{"key":"CIT0036","first-page":"385","volume":"10","author":"SCHOMIG A","year":"2000","journal-title":"Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. N Engl. J. Med."},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(00)01213-4"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00492-0"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1067\/mhj.2001.114971"},{"key":"CIT0040","first-page":"618","volume":"320","author":"THE TIMI STUDY GROUP","year":"1989","journal-title":"Result of the thrombolysis in MI (TIMI) Phase II trial. The TIMI Study Group. N Engl. J. Med."},{"key":"CIT0041","first-page":"1954","volume":"34","author":"ROSS AM","year":"1999","journal-title":"PACT investigators. Plasminogen-activator Angioplasty Compatibility Trial. J. Am. Coll. Cardiol"},{"key":"CIT0044","first-page":"1000","volume":"24","author":"HALEY EC","year":"1993","journal-title":"The TPA Bridging Study Group. Stroke"},{"key":"CIT0045","first-page":"1017","volume":"274","author":"HACKE W","year":"1995","journal-title":"The European Cooperative Acute Stroke Study (ECASS). JAMA"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.3.502"},{"key":"CIT0047","first-page":"769","volume":"30","author":"MANELFE C","year":"1999","journal-title":"VON KUMMER R etal.: Associate of hyperdense middle cerebral artery sign with clinical outcome in patients treated with tissue plasminogen activator. Stroke"},{"key":"CIT0048","first-page":"198","volume":"8","author":"STEINER T","year":"1998","journal-title":"Secondary analysis of ECASS by time stratification. ECASS Study Group. European Cooperative Acute Stroke Study. Cerebrovasc. Dis."},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.10.2073"},{"key":"CIT0050","first-page":"1245","volume":"17","author":"HACKE W","year":"1998","journal-title":"Second European-Australasian Acute Stroke Study Investigators. Lancet"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512143332401"},{"key":"CIT0052","first-page":"2119","volume":"28","author":"THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE RT-PA STROKE STUDY GROUP","year":"1997","journal-title":"Subgroup analysis of the NINDS t-PA Strole Trial. Stroke"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.2.429"},{"key":"CIT0054","first-page":"1781","volume":"340","author":"KWIATKOWSKI TG","year":"1999","journal-title":"National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl. J. Med."},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.55.11.1649"},{"key":"CIT0056","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.8.1544"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.7.1552"},{"key":"CIT0058","first-page":"424","volume":"53","author":"TANNE D","year":"1999","journal-title":"The t-PA Stroke Survey Group. Neurology"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1001\/jama.283.9.1145"},{"key":"CIT0060","first-page":"1151","volume":"9","author":"KATZAN IR","year":"2000","journal-title":"The Cleveland Area Experience. JAMA"},{"key":"CIT0062","first-page":"811","volume":"31","author":"CLARK WM","year":"2000","journal-title":"Thrombolytic therapy in acute ischaemic stroke study investigators. Stroke"},{"key":"CIT0063","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.2.298"},{"key":"CIT0064","first-page":"473","volume":"47","author":"QURESHI Al","year":"2000","journal-title":"SHATLA AA etal.: Intraarterial recombinant tissue plasminogen activator for ischaemic stroke: an accelerating dosing regimen. Neurosurgery"},{"key":"CIT0065","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.12.2598"},{"key":"CIT0066","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.31.11.2552"},{"key":"CIT0067","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.3.489"},{"key":"CIT0068","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(89)90524-X"},{"key":"CIT0069","first-page":"38","volume":"87","author":"THROMBOLYSIS IN MYOCARDIAL ISCHEMIA","year":"1993","journal-title":"Results of the Thrombolysis in Myocardial ischaemia (TIMI IIIA Circulation"},{"key":"CIT0070","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.4.1545"},{"key":"CIT0071","first-page":"1643","volume":"26","author":"ANDERSON HV","year":"1995","journal-title":"CI STONE PH et al.: One-year results of the Thrombolysis in Myocardial ischaemia (TIMI) IIIB clinical trial. A randomised comparison of tissue-type plasminogen activator versus placebo and early invasive versus early conservative strategies in unstable angina and non-Q wave MI. I Am. Coll. Cardial"},{"key":"CIT0072","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(95)00002-L"},{"key":"CIT0073","first-page":"293","volume":"2","author":"GOLDHABER SZ","year":"1988","journal-title":"HEIT Jet al.: Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism. Lancet"},{"key":"CIT0074","first-page":"239","volume":"19","author":"MEYER G","year":"1992","journal-title":"The European Cooperative Study Group for Pulmonary Embolism. I Am. Coll Cardial"},{"key":"CIT0076","first-page":"507","volume":"27","author":"GOLDHABER SZ","year":"1993","journal-title":"FELDSTEIN ML etal.: Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet"},{"key":"CIT0078","first-page":"718","volume":"106","author":"GOLDHABER SZ","year":"1994","journal-title":"conventional alteplase infusion for pulmonary embolism thrombolysis. An international multicenter randomised trial. The Bolus Alteplase Pulmonary Embolism Group. Chest"},{"key":"CIT0079","first-page":"1141","volume":"18","author":"MENEVEAU N","year":"1997","journal-title":"alteplase in massive pulmonary embolism. A randomised trial assesses right heart haemodynamics and pulmonary vascular obstruction. Eur. Heart J."},{"key":"CIT0080","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00068-0"},{"key":"CIT0084","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1055\/s-0038-1649919","volume":"74","author":"SCHWIEDER G","year":"1995","journal-title":"Thromb. Haemost."},{"key":"CIT0085","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.2.572"},{"key":"CIT0086","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-199409000-00003"},{"key":"CIT0087","first-page":"513","volume":"24","author":"WEAVER FA","year":"1996","journal-title":"The STILE Investigators. Surgery versus Thrombolysis for ischaemia of the Lower Extremity. I Vasc. Surg."},{"key":"CIT0088","first-page":"571","volume":"6","author":"BERO CJ","year":"1995","journal-title":"REDDY K etal.:Recombinant tissue plasminogen activator for the treatment of low extremity peripheral vascular occlusive disease. I Vasc. Interv. Radial."},{"key":"CIT0089","doi-asserted-by":"publisher","DOI":"10.1016\/S1078-5884(96)80283-8"},{"key":"CIT0090","first-page":"105","volume":"172","author":"COMEROTA AJ","year":"1996","journal-title":"Arta Surg."},{"key":"CIT0092","first-page":"646","volume":"84","author":"BRAITHWAITE BD","year":"1997","journal-title":"Thrombolysis Study Group. Br I Surg."},{"key":"CIT0093","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1055\/s-0038-1648911","volume":"72","author":"HAIRE WD","year":"1994","journal-title":"Thromb. Haemost."}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.10.11.2013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T22:15:43Z","timestamp":1550441743000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.10.11.2013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,11]]},"references-count":78,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2001,11]]}},"alternative-id":["10.1517\/13543784.10.11.2013"],"URL":"https:\/\/doi.org\/10.1517\/13543784.10.11.2013","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,11]]}}}